1,2-dimethylhydrazine decreases expression ISO RGD:1615947 6480464 1, 2-Dimethylhydrazine results in decreased expression of PTPRK mRNA CTD PMID:22206623 14-Deoxy-11,12-didehydroandrographolide increases expression ISO RGD:1354114 6480464 14-deoxy-11, 12-didehydroandrographolide results in increased expression of PTPRK mRNA CTD PMID:22101062 17beta-estradiol affects expression ISO RGD:1354114 6480464 Estradiol affects the expression of PTPRK mRNA CTD PMID:22574217 17beta-estradiol multiple interactions ISO RGD:1354114 6480464 [Estradiol co-treated with TGFB1 protein] results in increased expression of PTPRK mRNA CTD PMID:30165855 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO RGD:1615947 6480464 Tetrachlorodibenzodioxin affects the expression of PTPRK mRNA CTD PMID:21570461 2,3,7,8-tetrachlorodibenzodioxine decreases expression EXP 6480464 Tetrachlorodibenzodioxin results in decreased expression of PTPRK mRNA CTD PMID:32109520 3,4-methylenedioxymethamphetamine decreases expression ISO RGD:1615947 6480464 N-Methyl-3, 4-methylenedioxyamphetamine results in decreased expression of PTPRK mRNA CTD PMID:26251327 3,4-methylenedioxymethamphetamine increases methylation ISO RGD:1615947 6480464 N-Methyl-3, 4-methylenedioxyamphetamine results in increased methylation of PTPRK promoter CTD PMID:26251327 4,4'-sulfonyldiphenol increases expression ISO RGD:1615947 6480464 bis(4-hydroxyphenyl)sulfone results in increased expression of PTPRK mRNA CTD PMID:30951980 4,4'-sulfonyldiphenol decreases methylation ISO RGD:1615947 6480464 bis(4-hydroxyphenyl)sulfone results in decreased methylation of PTPRK exon CTD PMID:33297965 4-hydroxyphenyl retinamide increases expression ISO RGD:1615947 6480464 Fenretinide results in increased expression of PTPRK mRNA CTD PMID:28973697 5-aza-2'-deoxycytidine affects methylation ISO RGD:1354114 6480464 Decitabine affects the methylation of PTPRK gene CTD PMID:17630775 5-fluorouracil affects response to substance ISO RGD:1354114 6480464 PTPRK protein affects the susceptibility to Fluorouracil CTD PMID:16217747 6-propyl-2-thiouracil increases expression EXP 6480464 Propylthiouracil results in increased expression of PTPRK mRNA CTD PMID:24780913 acrolein multiple interactions ISO RGD:1354114 6480464 [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in decreased expression of and results in increased oxidation of PTPRK mRNA, [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in decreased expression of and results in increased oxidation of PTPRK mRNA CTD PMID:32699268 aflatoxin B1 affects expression ISO RGD:1354114 6480464 Aflatoxin B1 affects the expression of PTPRK protein CTD PMID:20106945 aflatoxin B1 decreases methylation ISO RGD:1354114 6480464 Aflatoxin B1 results in decreased methylation of PTPRK gene CTD PMID:27153756 aflatoxin B1 decreases expression ISO RGD:1354114 6480464 Aflatoxin B1 results in decreased expression of PTPRK mRNA CTD PMID:21641981 , PMID:22100608 aflatoxin B1 decreases expression ISO RGD:1615947 6480464 Aflatoxin B1 results in decreased expression of PTPRK mRNA CTD PMID:19770486 all-trans-retinoic acid decreases expression ISO RGD:1354114 6480464 Tretinoin results in decreased expression of PTPRK mRNA CTD PMID:17045167 alpha-pinene multiple interactions ISO RGD:1354114 6480464 [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in decreased expression of and results in increased oxidation of PTPRK mRNA, [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in decreased expression of and results in increased oxidation of PTPRK mRNA CTD PMID:32699268 ammonium chloride affects expression EXP 6480464 Ammonium Chloride affects the expression of PTPRK mRNA CTD PMID:16483693 amphetamine decreases expression EXP 6480464 Amphetamine results in decreased expression of PTPRK mRNA CTD PMID:30779732 antirheumatic drug increases expression ISO RGD:1354114 6480464 Antirheumatic Agents results in increased expression of PTPRK mRNA CTD PMID:24449571 aristolochic acid A decreases expression ISO RGD:1354114 6480464 aristolochic acid I results in decreased expression of PTPRK mRNA CTD PMID:33212167 arsenite(3-) multiple interactions ISO RGD:1354114 6480464 arsenite inhibits the reaction [G3BP1 protein binds to PTPRK mRNA] CTD PMID:32406909 benzo[a]pyrene decreases expression ISO RGD:1615947 6480464 Benzo(a)pyrene results in decreased expression of PTPRK mRNA CTD PMID:19770486 , PMID:21715664 benzo[a]pyrene decreases methylation ISO RGD:1615947 6480464 Benzo(a)pyrene results in decreased methylation of PTPRK intron CTD PMID:27901495 benzo[a]pyrene decreases expression ISO RGD:1354114 6480464 Benzo(a)pyrene results in decreased expression of PTPRK mRNA CTD PMID:20106945 more ... benzo[a]pyrene affects expression ISO RGD:1354114 6480464 Benzo(a)pyrene affects the expression of PTPRK mRNA CTD PMID:21714911 benzo[a]pyrene increases expression EXP 6480464 Benzo(a)pyrene results in increased expression of PTPRK mRNA CTD PMID:21839799 benzo[a]pyrene diol epoxide I decreases expression ISO RGD:1354114 6480464 7 more ... CTD PMID:19150397 bis(2-chloroethyl) sulfide increases expression ISO RGD:1615947 6480464 Mustard Gas results in increased expression of PTPRK mRNA CTD PMID:15674844 bisphenol A increases expression ISO RGD:1354114 6480464 bisphenol A results in increased expression of PTPRK mRNA, bisphenol A results in increased expression of PTPRK protein CTD PMID:25047013 , PMID:33376534 bisphenol A multiple interactions ISO RGD:1354114 6480464 [bisphenol A co-treated with Fulvestrant] results in increased methylation of PTPRK gene CTD PMID:31601247 bisphenol A decreases expression ISO RGD:1615947 6480464 bisphenol A results in decreased expression of PTPRK mRNA CTD PMID:33221593 bisphenol A increases expression ISO RGD:1615947 6480464 bisphenol A results in increased expression of PTPRK mRNA CTD PMID:30951980 bisphenol A increases methylation EXP 6480464 bisphenol A results in increased methylation of PTPRK gene CTD PMID:28505145 bisphenol A decreases expression EXP 6480464 bisphenol A results in decreased expression of PTPRK mRNA CTD PMID:30816183 bisphenol A increases expression EXP 6480464 bisphenol A results in increased expression of PTPRK mRNA CTD PMID:25181051 , PMID:34947998 bisphenol F increases expression ISO RGD:1615947 6480464 bisphenol F results in increased expression of PTPRK mRNA CTD PMID:30951980 bisphenol F multiple interactions ISO RGD:1354114 6480464 [bisphenol F co-treated with Fulvestrant] results in increased methylation of PTPRK gene CTD PMID:31601247 butanal decreases expression ISO RGD:1354114 6480464 butyraldehyde results in decreased expression of PTPRK mRNA CTD PMID:26079696 cadmium dichloride increases expression ISO RGD:1354114 6480464 Cadmium Chloride results in increased expression of PTPRK mRNA CTD PMID:26472689 caffeine decreases phosphorylation ISO RGD:1354114 6480464 Caffeine results in decreased phosphorylation of PTPRK protein CTD PMID:35688186 captan decreases expression ISO RGD:1615947 6480464 Captan results in decreased expression of PTPRK mRNA CTD PMID:31558096 carbon nanotube decreases expression ISO RGD:1615947 6480464 Nanotubes, Carbon analog results in decreased expression of PTPRK mRNA CTD PMID:25620056 CGP 52608 multiple interactions ISO RGD:1354114 6480464 CGP 52608 promotes the reaction [RORA protein binds to PTPRK gene] CTD PMID:28238834 chloroprene decreases expression ISO RGD:1615947 6480464 Chloroprene results in decreased expression of PTPRK mRNA CTD PMID:23125180 choline multiple interactions ISO RGD:1615947 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased expression of PTPRK mRNA CTD PMID:20938992 cisplatin decreases expression ISO RGD:1615947 6480464 Cisplatin results in decreased expression of PTPRK mRNA CTD PMID:24280081 cisplatin multiple interactions ISO RGD:1354114 6480464 Cisplatin promotes the reaction [jinfukang results in decreased expression of PTPRK mRNA], jinfukang promotes the reaction [Cisplatin results in decreased expression of PTPRK mRNA] CTD PMID:27392435 cisplatin decreases expression ISO RGD:1354114 6480464 Cisplatin results in decreased expression of PTPRK mRNA CTD PMID:19561079 , PMID:24280081 clofibrate decreases expression ISO RGD:1615947 6480464 Clofibrate results in decreased expression of PTPRK mRNA CTD PMID:23811191 copper(II) sulfate decreases expression ISO RGD:1354114 6480464 Copper Sulfate results in decreased expression of PTPRK mRNA CTD PMID:19549813 coumarin increases phosphorylation ISO RGD:1354114 6480464 coumarin results in increased phosphorylation of PTPRK protein CTD PMID:35688186 coumestrol decreases expression ISO RGD:1354114 6480464 Coumestrol results in decreased expression of PTPRK mRNA CTD PMID:19167446 crocidolite asbestos decreases expression ISO RGD:1615947 6480464 Asbestos, Crocidolite results in decreased expression of PTPRK mRNA CTD PMID:29279043 cyclosporin A decreases expression ISO RGD:1615947 6480464 Cyclosporine results in decreased expression of PTPRK mRNA CTD PMID:19770486 cyclosporin A decreases expression ISO RGD:1354114 6480464 Cyclosporine results in decreased expression of PTPRK mRNA CTD PMID:25562108 fenvalerate increases expression EXP 6480464 fenvalerate results in increased expression of PTPRK mRNA CTD PMID:30307764 flavonoids increases expression EXP 6480464 Flavonoids results in increased expression of PTPRK mRNA CTD PMID:18035473 folic acid multiple interactions ISO RGD:1615947 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased expression of PTPRK mRNA CTD PMID:20938992 folpet decreases expression ISO RGD:1615947 6480464 folpet results in decreased expression of PTPRK mRNA CTD PMID:31558096 fonofos increases methylation ISO RGD:1354114 6480464 Fonofos results in increased methylation of PTPRK promoter CTD PMID:22847954 formaldehyde decreases expression ISO RGD:1354114 6480464 Formaldehyde results in decreased expression of PTPRK mRNA CTD PMID:20655997 fulvestrant multiple interactions ISO RGD:1354114 6480464 [bisphenol A co-treated with Fulvestrant] results in increased methylation of PTPRK gene, [bisphenol F co-treated with Fulvestrant] results in increased methylation of PTPRK gene CTD PMID:31601247 gallic acid increases expression ISO RGD:1354114 6480464 Gallic Acid results in increased expression of PTPRK mRNA CTD PMID:34408198 gentamycin increases expression EXP 6480464 Gentamicins results in increased expression of PTPRK mRNA CTD PMID:33387578 GW 7647 decreases expression ISO RGD:1354114 6480464 GW 7647 results in decreased expression of PTPRK mRNA CTD PMID:31628012 GW 7647 decreases expression EXP 6480464 GW 7647 results in decreased expression of PTPRK mRNA CTD PMID:31628012 ivermectin decreases expression ISO RGD:1354114 6480464 Ivermectin results in decreased expression of PTPRK protein CTD PMID:32959892 L-methionine multiple interactions ISO RGD:1615947 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased expression of PTPRK mRNA CTD PMID:20938992 lipopolysaccharide multiple interactions ISO RGD:1354114 6480464 [S-(1, 2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of PTPRK mRNA CTD PMID:35811015 lipopolysaccharide increases expression ISO RGD:1354114 6480464 Lipopolysaccharides results in increased expression of PTPRK mRNA CTD PMID:35811015 methapyrilene decreases expression EXP 6480464 Methapyrilene results in decreased expression of PTPRK mRNA CTD PMID:30467583 methylmercury chloride decreases expression ISO RGD:1354114 6480464 methylmercuric chloride results in decreased expression of PTPRK mRNA CTD PMID:28001369 mifepristone increases expression ISO RGD:1354114 6480464 Mifepristone results in increased expression of PTPRK mRNA CTD PMID:17584828 N,N-diethyl-m-toluamide multiple interactions EXP 6480464 [Permethrin co-treated with DEET] results in decreased methylation of PTPRK gene CTD PMID:33148267 nickel dichloride increases expression ISO RGD:1354114 6480464 nickel chloride results in increased expression of PTPRK mRNA CTD PMID:17312168 ochratoxin A increases expression EXP 6480464 ochratoxin A results in increased expression of PTPRK mRNA CTD PMID:18417182 oxaliplatin multiple interactions EXP 6480464 [oxaliplatin co-treated with Topotecan] results in increased expression of PTPRK mRNA CTD PMID:25729387 ozone multiple interactions ISO RGD:1354114 6480464 [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in decreased expression of and results in increased oxidation of PTPRK mRNA more ... CTD PMID:32699268 ozone multiple interactions ISO RGD:1615947 6480464 [Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in decreased expression of PTPRK mRNA CTD PMID:34911549 p-toluidine decreases expression EXP 6480464 4-toluidine results in decreased expression of PTPRK mRNA CTD PMID:27638505 paracetamol increases expression ISO RGD:1354114 6480464 Acetaminophen results in increased expression of PTPRK mRNA CTD PMID:21420995 paracetamol affects response to substance ISO RGD:1354114 6480464 PTPRK gene polymorphism affects the susceptibility to Acetaminophen CTD PMID:26104854 paracetamol decreases expression ISO RGD:1354114 6480464 Acetaminophen results in decreased expression of PTPRK mRNA CTD PMID:22230336 parathion increases methylation ISO RGD:1354114 6480464 Parathion results in increased methylation of PTPRK promoter CTD PMID:22847954 pentanal decreases expression ISO RGD:1354114 6480464 pentanal results in decreased expression of PTPRK mRNA CTD PMID:26079696 perfluorooctane-1-sulfonic acid multiple interactions ISO RGD:1615947 6480464 [perfluorooctane sulfonic acid co-treated with Pectins] results in decreased expression of PTPRK mRNA CTD PMID:36331819 permethrin multiple interactions EXP 6480464 [Permethrin co-treated with DEET] results in decreased methylation of PTPRK gene CTD PMID:33148267 phenobarbital affects expression ISO RGD:1615947 6480464 Phenobarbital affects the expression of PTPRK mRNA CTD PMID:23091169 phenylephrine decreases expression EXP 6480464 Phenylephrine results in decreased expression of PTPRK mRNA CTD PMID:18158353 pirinixic acid decreases expression ISO RGD:1615947 6480464 pirinixic acid results in decreased expression of PTPRK mRNA CTD PMID:20813756 , PMID:23811191 potassium dichromate increases expression ISO RGD:1615947 6480464 Potassium Dichromate results in increased expression of PTPRK mRNA CTD PMID:23608068 progesterone affects expression ISO RGD:1615947 6480464 Progesterone affects the expression of PTPRK mRNA CTD PMID:17251523 quercetin decreases expression ISO RGD:1354114 6480464 Quercetin results in decreased expression of PTPRK mRNA CTD PMID:21632981 S-(1,2-dichlorovinyl)-L-cysteine multiple interactions ISO RGD:1354114 6480464 [S-(1, 2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of PTPRK mRNA CTD PMID:35811015 silicon dioxide decreases expression ISO RGD:1354114 6480464 Silicon Dioxide analog results in decreased expression of PTPRK mRNA CTD PMID:25895662 sodium arsenite increases expression ISO RGD:1354114 6480464 sodium arsenite results in increased expression of PTPRK protein CTD PMID:21925251 sodium arsenite decreases expression ISO RGD:1354114 6480464 sodium arsenite results in decreased expression of PTPRK mRNA CTD PMID:29301061 sodium dichromate affects expression EXP 6480464 sodium bichromate affects the expression of PTPRK mRNA CTD PMID:22110744 Soman decreases expression EXP 6480464 Soman results in decreased expression of PTPRK mRNA CTD PMID:19281266 sunitinib decreases expression ISO RGD:1354114 6480464 Sunitinib results in decreased expression of PTPRK mRNA CTD PMID:31533062 Tanshinone I decreases expression ISO RGD:1354114 6480464 tanshinone results in decreased expression of PTPRK mRNA CTD PMID:15849732 taurine decreases expression ISO RGD:1354114 6480464 Taurine results in decreased expression of PTPRK mRNA CTD PMID:16579726 temozolomide decreases expression ISO RGD:1354114 6480464 Temozolomide results in decreased expression of PTPRK mRNA CTD PMID:31758290 terbufos increases methylation ISO RGD:1354114 6480464 terbufos results in increased methylation of PTPRK promoter CTD PMID:22847954 testosterone decreases expression ISO RGD:1615947 6480464 Testosterone results in decreased expression of PTPRK mRNA CTD PMID:21669218 tetrachloromethane affects expression ISO RGD:1615947 6480464 Carbon Tetrachloride affects the expression of PTPRK mRNA CTD PMID:17484886 thapsigargin decreases expression ISO RGD:1615947 6480464 Thapsigargin results in decreased expression of PTPRK protein CTD PMID:24648495 thimerosal increases expression ISO RGD:1354114 6480464 Thimerosal results in increased expression of PTPRK mRNA CTD PMID:27188386 topotecan multiple interactions EXP 6480464 [oxaliplatin co-treated with Topotecan] results in increased expression of PTPRK mRNA CTD PMID:25729387 topotecan affects response to substance ISO RGD:1354114 6480464 PTPRK protein affects the susceptibility to Topotecan CTD PMID:16217747 trichloroethene increases methylation EXP 6480464 Trichloroethylene results in increased methylation of PTPRK gene CTD PMID:27618143 trichostatin A increases expression ISO RGD:1354114 6480464 trichostatin A results in increased expression of PTPRK mRNA CTD PMID:24935251 trimellitic anhydride decreases expression ISO RGD:1615947 6480464 trimellitic anhydride results in decreased expression of PTPRK mRNA CTD PMID:19042947 triptonide increases expression ISO RGD:1615947 6480464 triptonide results in increased expression of PTPRK mRNA CTD PMID:33045310 troglitazone decreases expression ISO RGD:1615947 6480464 troglitazone results in decreased expression of PTPRK mRNA CTD PMID:28973697 valproic acid affects expression ISO RGD:1354114 6480464 Valproic Acid affects the expression of PTPRK mRNA CTD PMID:25979313 valproic acid decreases expression ISO RGD:1354114 6480464 Valproic Acid results in decreased expression of PTPRK mRNA CTD PMID:23179753 , PMID:27188386 vinclozolin decreases expression EXP 6480464 vinclozolin results in decreased expression of PTPRK mRNA CTD PMID:23034163 vinclozolin increases methylation EXP 6480464 vinclozolin results in increased methylation of PTPRK gene CTD PMID:31079544 vincristine increases expression ISO RGD:1354114 6480464 Vincristine results in increased expression of PTPRK mRNA CTD PMID:23649840
